Close Menu

The Boston Globe takes a look at Knome, the consumer genomic company that sequences its customers' genomes while rounding up the challenges facing the field -- those cease-and-desist letters and the debate over medical relevance. The writer, Scott Kirsner, asks Raju Kucherlapati and David Altshuler if they'd get their genomes sequenced.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.